Jefferies reiterated coverage on Pinduoduo with a new price target
$PDD
Business Services
Consumer Discretionary
Jefferies reiterated coverage of Pinduoduo with a rating of Buy and set a new price target of $151.00 from $193.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/21/2025 | $137.00 → $130.00 | Buy → Neutral | Nomura |
| 11/22/2024 | Overweight → Neutral | Analyst | |
| 10/7/2024 | $126.00 → $224.00 | Neutral → Outperform | Macquarie |
| 8/27/2024 | $194.00 → $120.00 | Buy → Neutral | Citigroup |
| 8/26/2024 | Outperform → Neutral | Macquarie | |
| 8/26/2024 | $193.00 → $151.00 | Buy | Jefferies |
| 5/24/2024 | $145.00 → $184.00 | Neutral → Buy | Goldman |
| 3/11/2024 | $136.00 | Buy → Neutral | Goldman |
DUBLIN and SHANGHAI, March 20, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the fourth quarter ended and the fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Total revenues in the quarter were RMB110,610.1 million (US$115,153.5 million), an increase of 24% from RMB88,881.0 million in the same quarter of 2023.Operating profit in the quarter was RMB25,592.2 million (US$3,506.1 million), an increase of 14% from RMB22,395.0 million in the same quarter of 2023. Non-GAAP2 operating profit in the quarter was RMB27,99
DUBLIN and SHANGHAI, March 13, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD) today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024, before U.S. markets open on Thursday, March 20, 2025. The Company's management will hold an earnings conference call at 7:30 AM ET on March 20, 2025 (11:30 AM GMT and 7:30 PM HKT on the same day). The conference call will be webcast live at https://investor.pddholdings.com/investor-events. The webcast will be available for replay at the same website following the conclusion of the call. About PDD Holdings: PDD Holdings is a multinational
Bioptimus announces a $76M funding milestone, with the latest injection of $41M led by Cathay Innovation less than 12 months from its initial seed round Since the successful release of the largest AI foundation model for pathology in July, the company has been continuing its groundbreaking work and is now poised to release a breakthrough new multi-scale, multi-modal foundation model for biology in 2025 The new model will allow the simulation of biology at unprecedented scale and dimension, creating biological innovation for medical, biotech, cosmetic industries, and beyond Bioptimus, the pioneering AI foundation model company, announced today that it has reached a significant fu
Nomura downgraded PDD Holdings from Buy to Neutral and set a new price target of $130.00 from $137.00 previously
Analyst downgraded Pinduoduo from Overweight to Neutral
Macquarie upgraded Pinduoduo from Neutral to Outperform and set a new price target of $224.00 from $126.00 previously
DUBLIN and SHANGHAI, March 20, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the fourth quarter ended and the fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Total revenues in the quarter were RMB110,610.1 million (US$115,153.5 million), an increase of 24% from RMB88,881.0 million in the same quarter of 2023.Operating profit in the quarter was RMB25,592.2 million (US$3,506.1 million), an increase of 14% from RMB22,395.0 million in the same quarter of 2023. Non-GAAP2 operating profit in the quarter was RMB27,99
DUBLIN and SHANGHAI, March 13, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD) today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024, before U.S. markets open on Thursday, March 20, 2025. The Company's management will hold an earnings conference call at 7:30 AM ET on March 20, 2025 (11:30 AM GMT and 7:30 PM HKT on the same day). The conference call will be webcast live at https://investor.pddholdings.com/investor-events. The webcast will be available for replay at the same website following the conclusion of the call. About PDD Holdings: PDD Holdings is a multinational
DUBLIN and SHANGHAI, Nov. 21, 2024 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Total revenues in the quarter were RMB99,354.4 million (US$1 14,157.9 million), an increase of 44% from RMB68,840.4 million in the same quarter of 2023. Operating profit in the quarter was RMB24,292.5 million (US$3,461.6 million), an increase of 46% from RMB16,656.0 million in the same quarter of 2023. Non-GAAP2 operating profit in the quarter was RMB26,770.5 million (US$3,814.8 million), an increase of 48% from RMB18,125.8 million
SC 13G/A - PDD Holdings Inc. (0001737806) (Subject)
SC 13G/A - PDD Holdings Inc. (0001737806) (Subject)
SC 13G/A - PDD Holdings Inc. (0001737806) (Subject)
6-K - PDD Holdings Inc. (0001737806) (Filer)
6-K - PDD Holdings Inc. (0001737806) (Filer)
6-K - PDD Holdings Inc. (0001737806) (Filer)
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced the successful completion of a $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D Eme
The new face of wealth management creates ai powered software to drive optimization; membership is increasing 20% MoM, Appoints Chris Davidson of House Call Pro as CTO MCLEAN, Va., Nov. 26, 2024 /PRNewswire/ -- Range, the all-in-one AI WealthTech platform, raised $28 million in Series B funding, led by Cathay Innovation and joined by Gradient Ventures and other investors. This round brings the company's total funding to $40 million. Traditional financial advisors have offered the same types of wealth management services to consumers for decades. Range is overhauling the sector